Using RNA sequencing, they reported a decrease in GLP-1 cell lineage, GLP-1 maturation from proglucagon, and a significant reduction of GLP-1 positive cells in jejunal samples of obese subjects with T2D compared to obese individuals who do not have T2D. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.